Dec 03, 2024
https://www.prnewswire.com/news-releases/vivebiotech-secures-growth-investment-from-ampersand-capital-partners-to-expand-lentiviral-vector-development-and-manufacturing-capabilities-302321813.html
Ampersand Capital Partners has invested $0 in VIVEbiotech S.L.